Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenomics of Anti-Platelet Interventions (The PAPI Study)

NCT00799396 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.

NCT NCT00799396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00799396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenomics of Anti-Platelet Interventions (The PAPI Study)
Lead sponsor
University of Maryland, Baltimore
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2006
Completion date
February 29, 2012
Enrollment
682 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease, platelet aggregation inhibitors